Wednesday, February 15, 2017

AXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO

Axsome Therapeutics Inc.'s (AXSM) drug candidate AXS-05 has received Fast Track status from the FDA for treatment resistant depression.

from RTT - Biotech http://ift.tt/2lguu3o
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)